QUIKSPOON

Serial Number 77614681
606

Registration Progress

Application Filed
Nov 14, 2008
Under Examination
Sep 29, 2009
Approved for Publication
Jun 17, 2009
Published for Opposition
Jul 7, 2009
Registered

Basic Information

Serial Number
77614681
Filing Date
November 14, 2008
Published for Opposition
July 7, 2009
Abandonment Date
October 29, 2012
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Oct 29, 2012
Classes
001 005

Rights Holder

The Ritedose Corporation

03
Address
Carolina Research Park
Columbia, SC 29203

Ownership History

Holopack International Corporation

Original Applicant
03
Columbia, SC

Holopack International Corporation

Owner at Publication
03
Columbia, SC

The Ritedose Corporation

New Owner After Publication #1
03
Columbia, SC

Legal Representation

Attorney
Marcia T. Greci

USPTO Deadlines

All Deadlines Cleared

All 5 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

50 events
Date Code Type Description
Oct 29, 2012 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Oct 29, 2012 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Feb 10, 2012 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 9, 2012 EX5G S SOU EXTENSION 5 GRANTED
Feb 6, 2012 EEXT I SOU TEAS EXTENSION RECEIVED
Feb 6, 2012 EXT5 S SOU EXTENSION 5 FILED
Oct 1, 2011 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 30, 2011 EX4G S SOU EXTENSION 4 GRANTED
Sep 28, 2011 EEXT I SOU TEAS EXTENSION RECEIVED
Sep 28, 2011 EXT4 S SOU EXTENSION 4 FILED
Apr 1, 2011 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 31, 2011 EX3G S SOU EXTENSION 3 GRANTED
Mar 29, 2011 EEXT I SOU TEAS EXTENSION RECEIVED
Mar 29, 2011 EXT3 S SOU EXTENSION 3 FILED
Oct 5, 2010 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 4, 2010 EX2G S SOU EXTENSION 2 GRANTED
Sep 29, 2010 EEXT I SOU TEAS EXTENSION RECEIVED
Sep 29, 2010 EXT2 S SOU EXTENSION 2 FILED
Apr 21, 2010 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 20, 2010 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 20, 2010 EX1G S SOU EXTENSION 1 GRANTED
Mar 29, 2010 EEXT I SOU TEAS EXTENSION RECEIVED
Mar 29, 2010 EXT1 S SOU EXTENSION 1 FILED
Nov 18, 2009 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 29, 2009 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT
Sep 16, 2009 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Sep 9, 2009 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Jul 7, 2009 PUBO A PUBLISHED FOR OPPOSITION
Jun 17, 2009 NPUB O NOTICE OF PUBLICATION
Jun 1, 2009 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 1, 2009 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED
May 14, 2009 ZZZX Z PREVIOUS ALLOWANCE COUNT WITHDRAWN
May 8, 2009 PBCR Z WITHDRAWN FROM PUB - OG REVIEW QUERY
Apr 30, 2009 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 30, 2009 ALIE A ASSIGNED TO LIE
Apr 30, 2009 ALIE A ASSIGNED TO LIE
Apr 30, 2009 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 29, 2009 CNRT R NON-FINAL ACTION WRITTEN
Apr 29, 2009 GNRT O NON-FINAL ACTION E-MAILED
Apr 29, 2009 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 29, 2009 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 29, 2009 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 29, 2009 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 27, 2009 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 27, 2009 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 27, 2009 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 17, 2009 CNRT R NON-FINAL ACTION WRITTEN
Feb 17, 2009 GNRT F NON-FINAL ACTION E-MAILED
Feb 17, 2009 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 13, 2009 DOCK D ASSIGNED TO EXAMINER

Detailed Classifications

Class 001
carbohydrates used as an ingredient or as an integral component in nutraceuticals
First Use Anywhere: 0
First Use in Commerce: 0
Class 005
Containers filled with pharmaceutical oral liquid medicines for the treatment of colds, allergies, coughs, sinus ailments, analgesics for pain management, fevers, gastrointestinal and digestive ailments, cardiovascular and circulatory ailments, blood anomalies, respiratory ailments, muscular-skeletal disorders, eye disorders, oral-ear-nose and throat problems, parasitic problems, endocrine problems, male and female sexual performance problems, reproductive system problems, oral contraceptive, urologic and urinary tract problems, hormone deficiencies, skin disorders, infections and infestations, neurological problems, insomnia, hair loss and immunologic ailments; Nutraceuticals, namely, botanicals, fiber supplements, namely, lipid lowering agents, fish oil used as a nutritional supplement; omega-3 fatty acids, dietary supplements, vitamins, mineral supplements, homeopathic supplements, protein supplements, natural growth hormone supplements, dietary supplements containing metabolites, and medicinal root, plant, and herb extracts, for the treatment of vitamin and mineral deficiencies, fiber deficiencies, sports nutritional deficiencies, general nutritional deficiencies, immune deficiencies, antioxidant deficiencies, protein deficiencies, colds and cold preventions, allergies, coughs, sinus ailments, digestive and diet issues, energy and vitality issues, joint and muscular-skeletal issues, cardiovascular and circulatory issues, memory issues, insomnia, urologic and urinary tract problems, hair loss, skin conditions, and hormone deficiencies; Medical liquids, namely, oral antibiotics, otic antibiotics, nasal saline drop preparations and decongestant nasal sprays, topical hand sanitizing preparations for oral delivery, eye delivery, nasal delivery, ear delivery, rectal delivery, vaginal delivery, topical use, and for external delivery by syringes, crucibles and cups; veterinary preparations for dogs, cats, birds, fish, and reptiles for the treatment of vitamin and mineral treatment, joint and muscular issues, oral and dental care, digestive aids and issues, namely, deworming preparations, allergy problems, behavioral problems, eye and ear problems, and skin and coat care; dental and periodontal care products, namely, medicated mouthwash for the treatment of plaque, gingivitis, periodontitis and gum health issues in humans, felines, and canines, oral dental rinses, medicated mouthwash for plaque prevention, fluoride additives, and denture adhesives; liquid medical food, namely, processed food adapted for medical purposes, infant formula, infant gas relief drops, and dietary fiber as an additive for food products for the treatment of vitamin and mineral deficiencies, fiber deficiencies, digestive issues, tube feeding, weight control and nutritional feeding
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Pseudo Mark
QUICK SPOON

Classification

International Classes
001 005